Toward disease-modifying therapies in type 1 diabetes: focus on teplizumab
Mathieu C, Sims EK, Chatenoud L, et al.
Diabetes Care. Pub. online 6 Nov 2025.
Leggi
Mathieu C, Sims EK, Chatenoud L, et al.
Diabetes Care. Pub. online 6 Nov 2025.
Leggi
Conlin PR, Prentice JC, Mohr DC, et al.
BMJ Open Diabetes Res Care. Pub. online 4 Nov 2025.
Leggi
Astbury NM, Ripullone K, Ramakrishnan R, et al.
Diabetes Obes Metab. Pub. online 5 Nov 2025.
Leggi
Muskiet MHA, Nardone M, Rensen PCN, et al.
Lancet. Pub. online 6 Nov 2025.
Leggi
Astbury NM, Ripullone K, Ramakrishnan R, et al.
Diabetes Obes Metab. Pub. online 5 Nov 2025.
Leggi
le Roux CW, Wharton S, Bozkurt B, et al.
Diabetes Obes Metab. Pub. online 4 Nov 2025.
Leggi
Muskiet MHA, Nardone M, Rensen PCN, et al.
Lancet. Pub. online 6 Nov 2025.
Leggi
Billings LK, Hsia S, Bays H, et al.
Lancet. Pub. online 6 Nov 2025.
Leggi
Chiang KE, Padilla HM, Callands TA, et al.
JAMA Netw Open. Pub. online 3 Nov 2025.
Leggi
Gitelman SE, Simmons K, Sherr JL, et al.
Diabetologia. Pub. online 6 Nov 2025.
Leggi